Across TCGA pan-cancer cohorts, MIR1185-1 Mutation is linked to patient survival in 2 of 34 cancer types, making it a survival-associated MIR1185-1 data layer compared with 10 for mass-spec protein.

The strongest signal is observed in breast invasive carcinoma (BRCA), where higher MIR1185-1 Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated MIR1185-1 expression acts as an unfavorable survival marker.

BRCA and SKCM are the cancer types where MIR1185-1 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
BRCA	OS	Median	All	0.287	0.924	<.001	36	view →
SKCM	DFS	Median	All	0.046	0.738	<.001	6	view →

Pink = unfavorable, green = favorable. Showing the 2 strongest of 2 lineages.

Exploration

Same gene, other analysis: MIR1185-1 tumor-vs-normal RNA expression · all MIR1185-1 data types